CN108840950A - A kind of fusion protein and preparation method thereof being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha - Google Patents

A kind of fusion protein and preparation method thereof being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha Download PDF

Info

Publication number
CN108840950A
CN108840950A CN201810768483.8A CN201810768483A CN108840950A CN 108840950 A CN108840950 A CN 108840950A CN 201810768483 A CN201810768483 A CN 201810768483A CN 108840950 A CN108840950 A CN 108840950A
Authority
CN
China
Prior art keywords
pig
ifn
interferon
fusion protein
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201810768483.8A
Other languages
Chinese (zh)
Inventor
高耀辉
周炜
郭志燕
何志远
单雪芹
鲍可兵
付超
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhu Phil Biological Products Industry Research Institute Co Ltd
Original Assignee
Wuhu Phil Biological Products Industry Research Institute Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhu Phil Biological Products Industry Research Institute Co Ltd filed Critical Wuhu Phil Biological Products Industry Research Institute Co Ltd
Publication of CN108840950A publication Critical patent/CN108840950A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/55IL-2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/56IFN-alpha
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/57IFN-gamma
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/22Vectors comprising a coding region that has been codon optimised for expression in a respective host

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)

Abstract

The fusion protein and preparation method thereof that the invention discloses a kind of to be made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha; the fusion protein is connected through flexible linker by pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha and is formed, and is freeze-dried to obtain Recombinant Swine long-acting interferon after fusion protein and freeze drying protectant mixture.The Recombinant Swine long-acting interferon is remarkably improved the half-life period of pig interferon, and the half-life period of more common pig interferon improves 19 times or more, and has broad-spectrum disease resistance toxic action and can improve the immune response of pig itself.

Description

A kind of fusion being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha Albumen and preparation method thereof
Technical field
The invention belongs to technical field of biological genetic engineering, and in particular to by pig interleukin 2 and 6, Porcine interferon-gamma and pig The fusion protein and preparation method thereof of interferon-' alpha ' composition.
Background technique
Scale Compact Develop is rapidly growing in China in recent years, and China's live pig breeding stock and pork production are sure to occupy First place in the world, traditional swine disease control method is far from the control for adapting to infectious disease in extensive intensive pig production production.I Newly there are nearly 20 kinds of livestock and poultry infectious diseases in the past 20 years in state, in addition original animal epidemic, causes aquaculture industry of China huge Economic loss.According to incompletely statistics, China is every year because various viral diseases cause mortality of livestock to be up to 15%-20%, Economic loss reaches billions of members.
Mainly pass through vaccine inoculation to the prevention and treatment approach of porcine viral diseases at present and uses antibiotic, but by It is not perfect in breeding environment, virus variation and Abwehrkraft des Koepers variation etc. reasons, make traditional prevention and treatment approach by Huge challenge, most of antibiotics and traditional oral antiviral medicament give people due to medicament residue problem Health is brought a negative impact;And traditional vaccine, high specific and side effect due to it, virus variation and new can not be resisted Type virus, which continuously emerges, gives pig aquaculture bring significant damage.
IFN is that a kind of virus infection induction body generates and has broad-spectrum antiviral, antitumor and with immunoregulation effect Protein, nineteen fifty-seven Issacs and Lindeman first discovery, it is a kind of multi-functional cell factor, with cell receptor knot After conjunction, it can induce body and generate a variety of specific proteins and enzyme, it is main by inhibiting viral gene transcription and degradation virus RNA inhibits the growth and breeding of virus and plays antitumor etc. activity.Now it is known that α type IFN in vivo can be selectively Act on the infection cells such as virus, by inhibit infected cell in virus protein biosynthesis, play wide spectrum and efficiently Antivirus action.But it is faint without acting on or acting on to normal host cell.IFN-α main physiological activity is with inhibition virus Duplication, anti parasitic, the killing activity for inhibiting various kinds of cell proliferation, stimulation immunocyte.
γ type IFN is that the T cell and NK cell by activating generate, and has relatively strong antiviral and immunoloregulation function.Largely Studies have shown that interferon gamma also plays crucial adjustment effect other than having the function of broad-spectrum antiviral, to immune system, so IFN-γ is also known as immunological regulation interferon.Although various types of interferon can mediated cell to the anti-of virus infection It answers, but the immunoregulatory activity of interferon gamma is coordinating immune response and determining in the long-term antiviral state of body to play more Important role, therefore interferon gamma has particularly important clinical value.
Cell factor IL-2, that is, interleukin 2 also known as t cell growth factor.Mainly produced by the T lymphocyte activated The raw cell factor with extensive bioactivity can both promote lymphopoiesis, enhance immune function, and can restricted T Cell effect and the immune tolerance for enhancing body, therefore can be used for treating tumour, infectious diseases and autoimmune disease.In beast In doctor, since IL-2 can improve the immune response of vaccine and reduce the generation of disease, also there is wide application prospect.IL-2 because The immune level that body can be enhanced improves the disease resistance of body, thus for bacillary, viral and parasitic diseases Immunization therapy.In addition, IL-2 can also influence the metabolism of drug, extend the metabolism time of drug, action time increases, to mention High curative effect of medication.
The limitation of natural interferon and artificial recombination interferon generally existing half-life short at present, half-life period are generally 2-4 A hour.Half-life short brings great inconvenience, the increase for the treatment of number of times, corresponding time cost and economic cost to treatment Increase therewith, and the tenability limit of body is also possible to be broken the generation for leading to adverse reaction.The main reason for half-life short There are two:The too small tachytrophism in vivo of the molecular weight of interferon, interferon especially recombinant interferon affinity is poor to be exempted from Epidemic disease system is removed.
And common long-acting interferon is using polyethylene glycol fused interferon as representative on the market, only in the level of molecular weight Part solves the problems, such as that interferon molecule amount is small and leads to half-life short, while polyethylene glycol fused interferon cost is very Height is unfavorable for clinically applying.
Summary of the invention
It is interfered in order to solve the above technical problems, the present invention provides one kind by pig interleukin 2 and 6, Porcine interferon-gamma and pig The fusion protein and preparation method thereof of plain α composition, and thus after fusion protein and freeze drying protectant mixture, freeze-dried system Standby to obtain a kind of Recombinant Swine long-acting interferon, the Recombinant Swine long-acting interferon is remarkably improved the half-life period of pig interferon, compared with The half-life period of common pig interferon improves 19 times or more, and has broad-spectrum disease resistance toxic action and can improve the immune of pig itself and answer It answers.
The technical scheme adopted by the invention is as follows:
A kind of fusion protein being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha, the fusion protein Amino acid sequence table as shown in 400 < of SEQUENCE LISTING, 1 >.
The present invention also provides the gene for encoding above-mentioned fusion protein, the nucleotides sequence list such as SEQUENCE of the gene Shown in 400 < of LISTING, 2 >, it is denoted as genome 1;Or as shown in 400 < of SEQUENCE LISTING, 3 >, it is denoted as genome 2.
Fusion protein described in the genome 1 and the equal codified of the genome 2.Genome 2 is the nucleosides to genome 1 Acid sequence optimize after as a result, when usual codon adaptation indexI CAI=1.0 be considered the gene in the expression system In be optimal high efficient expression state, CAI value is lower to show that expression is lower in host.Most ideal point of G/C content in gene Cloth range is 30~70%, is more than that the range will affect translation and transcriptional efficiency in any region.It is sent out using software detection The now codon of pig interleukin 2 and 6, porcine IFN γ, pig IFN-α original gene codon adaptation indexI in Escherichia coli (CAI) be respectively 0.23,0.24,0.22, GC percentage be 38.7%, 39.2%, 59.1%;And by pig interleukin 2, obtained after porcine IFN γ, pig IFN-α gene optimization each gene in Escherichia coli codon adaptation indexI (CAI) be 0.97, 1.0,1.0, GC percentage 47.6%, 45.4%, 55.6%.The utilization rate of low codon is significantly reduced by gene optimization, Influence of the rare codon to protein expression is avoided, the G/C content of gene is improved, improves transcription and translation efficiency.
The present invention also provides the expression vectors containing genome 1 or genome 2.
Further, the expression vector is the pET-32a coli expression carrier containing genome 1 or genome 2.
The present invention also provides the genetic engineering bacteriums containing genome 1 or genome 2.
Further, the genetic engineering bacterium is pET-32a/rIL2-IFN γ-IFN α.
Host cell containing genome 1 or genome 2 also belongs to protection scope of the present invention, further, the place Chief cell is e. coli host cell, and further, the e. coli host cell is BL21 (DE3) competent cell Or BL21 (DE3) competent cell with pGro7 plasmid.
The present invention also provides a kind of Recombinant Swine long-acting interferon, the Recombinant Swine long-acting interferon is by the fusion egg It is freeze-dried to form after the white mixture with freeze drying protectant.
The freeze drying protectant is glycerol, mannitol and sucrose, is buffer, the final concentration of three with 10mmol/L PBS For glycerol 100mL/L, mannitol 0.12g/mL and sucrose 0.025g/mL.
The invention also discloses the preparation methods of the fusion protein, and the preparation method comprises the following steps:It will contain The expression vector of genome 1 or genome 2 is imported into e. coli host cell, obtains genetic engineering bacterium, genetic engineering bacterium The crude product of the fusion protein is obtained after IPTG inducing expression, and fusion protein can be obtained after purified.
The expression vector is the pET-32a coli expression carrier containing genome 1 or genome 2;
The genetic engineering bacterium is pET-32a/rIL2-IFN γ-IFN α, and preparation method is:
(1) design primer, is obtained or the pig interleukin of the flexible linker sequence of artificial synthesized band by reverse transcription 2, the target gene of Porcine interferon-gamma, porcine interferon alpha;By flexible linker by pig interleukin 2 and 6, Porcine interferon-gamma, pig The target gene of interferon-' alpha ' connects, the nucleotides sequence list of the target gene after connection such as SEQUENCE LISTING Shown in 400 <, 2 > or as shown in 400 < of SEQUENCE LISTING, 3 >;
(2) target gene after connection is connected on pET-32a plasmid and obtains expression vector;
(3) expression vector is imported into e. coli host cell, genetic engineering bacterium pET-32a/rIL2- can be obtained IFNγ-IFNα。
The e. coli host cell is BL21 (DE3) competent cell or BL21 (DE3) sense with pGro7 plasmid By state cell.
The method of the purifying is:The crude product of fusion protein is successively through affinity chromatography, anion-exchange chromatography and molecular sieve Chromatographic purifying.
BL21 (DE3) competent cell with pGro7 plasmid is purchased from Shanghai Jinan Technology Co., Ltd./glad hundred promise Biology, article No. V205.
The acquisition methods of the genome 1 are:
A. design of primers
The primer sequence of pig interleukin 2 and 6 (IL-2) is:
Upstream IL-2-F1:CATGCCATGGATGTATAAGATGCAGCT has NcoI restriction enzyme site;
Downstream IL-2-R1:ACCACCACCAGAACCACCACCACCAGTCAGTGTTGAGTAG, with flexible linker;
The primer sequence of Porcine interferon-gamma (IFN-γ) is:
Upstream IFN-γ-F1:GGTGGTTCTGGTGGTGGTGGTTCTATGAGTTATACAACTT, with flexible linker;
Downstream IFN-γ-R1:ACCACCACCAGAACCACCACCACCTTTTGATGCTCTCTG, with flexible linker;
The primer sequence of porcine interferon alpha (IFN-α) is:
Upstream IFN-α-F1:GGTGGTTCTGGTGGTGGTGGTTCTATGTGTTCCTATTTA, with flexible linker;
Downstream IFN-α-R1:CCCTCGAGCTCCTTCCTCCTGAG has XhoI restriction enzyme site;
B. RNA is extracted from pig liver, and the target gene of pig IL-2, porcine IFN γ and pig IFN-α is obtained by reverse transcription, The gene order of three respectively as shown in 400 < of SEQUENCE LISTING, 4 >, 400 < of SEQUENCE LISTING, 5 > and Shown in 400 < of SEQUENCE LISTING, 6 >;
Respectively using the target gene of pig IL-2, porcine IFN γ and pig IFN-α as template, and it is utilized respectively pig IL-2, pig The upstream and downstream primer of IFN-γ and pig IFN-α carries out PCR amplification, respectively obtains the pig IL-2 for connecting flexible linker, pig IFN-γ and pig IFN-α gene.
PCR reaction system and condition are:In the overall reaction system of 25 μ L, 1.5 μ L of template ribonucleic acid, upstream and downstream primer is each 0.5 μ L, 2.5 μ L, dNTP Mix of reverse transcriptase are 10 μ L, add RNase Free water to 25 μ L;The reaction of the RT-PCR reaction Condition is:50 DEG C of reverse transcriptions 30min, 95 DEG C of initial denaturation 4min, into circulation;95 DEG C of denaturation 45s, 58 DEG C of annealing 45s, 72 DEG C are prolonged 1kb/min is stretched, is recycled 35 times, last 72 DEG C of extensions 10min.
C. rIL2-IFN γ gene is obtained using flexible linker connection pig IL-2 and porcine IFN γ target gene
The PCR reaction system and reaction condition of connection be:In the overall reaction system of 25 μ L, connect flexible linker's 1 μ L of IL-2 gene template DNA connects 1 μ L, IL-2 upstream primer of IFN-γ template DNA, the 0.5 μ L of flexible linker, 0.5 μ L, Taq archaeal dna polymerase of IFN-γ downstream primer, 2.5 μ L, dNTP Mix is 10 μ L, adds RNase Free water to 25 μ L;Even Connecing PCR reaction condition is:95 DEG C of initial denaturation 4min, into circulation:94 DEG C of denaturation 45s;58 DEG C of annealing 45s, 72 DEG C of extension 1kb/ Min, totally 35 recycle;Last 72 DEG C of extensions 10min.
D. rIL2-IFN γ-IFN is obtained using flexible linker connection rIL2-IFN γ gene and pig IFN-α target gene α gene
The PCR reaction system and reaction condition of connection be:In the overall reaction system of 25 μ L, rIL2-IFN γ gene template 1 μ L of DNA connects 1 μ L, IL-2 upstream primer of IFN-α template DNA, the 0.5 μ L of flexible linker, IFN-α downstream primer 0.5 2.5 μ L, dNTP Mix of μ L, Taq archaeal dna polymerase is 10 μ L, adds RNase Free water to 25 μ L;Connecting PCR reaction condition is: 95 DEG C of initial denaturation 4min, into circulation:94 DEG C of denaturation 45s;58 DEG C of annealing 45s, 72 DEG C of extension 1kb/min, totally 35 recycle;Most 72 DEG C of extension 10min afterwards.
Genome 2 is artificial synthesized gene after optimizing to genome 1, the acquisition methods of the genome 2 For:
A. design of primers
The primer sequence of pig interleukin 2 and 6 (IL-2) is:
Upstream IL-2-F2:CATGCCATGGATGTACAAAATGCAGC has NcoI restriction enzyme site;
Downstream IL-2-R2:ACCACCACCAGAACCACCACCACCGGTCAGGGTAGAGTAG, with flexible linker;
The primer sequence of Porcine interferon-gamma (IFN-γ) is:
Upstream IFN-γ-F2:GGTGGTTCTGGTGGTGGTGGTTCTATGTCTTACACCACCT, with flexible linker;
Downstream IFN-γ-R2:ACCACCACCAGAACCACCACCACCTTTAGAAGCACGCTG, with flexible linker;
Porcine interferon alpha (IFN-α):
Upstream IFN-α-F2:GGTGGTTCTGGTGGTGGTGGTTCTATGTGCTCTTACCTG, with flexible linker;
Downstream IFN-α-R2:CCCTCGAGTTCTTTACGACGCAG has XhoI restriction enzyme site.
B. the target gene of the pig IL-2, porcine IFN γ and pig IFN-α, the gene order of three is respectively such as SEQUENCE Shown in 400 < of LISTING, 7 >, 400 < of SEQUENCE LISTING 400 <, 8 > and SEQUENCE LISTING, 9 >;
Respectively using the target gene of pig IL-2, porcine IFN γ and pig IFN-α as template, and it is utilized respectively pig IL-2, pig The upstream and downstream primer of IFN-γ and pig IFN-α carries out PCR amplification, respectively obtains the pig IL-2 for connecting flexible linker, pig IFN-γ and pig IFN-α gene.
PCR reaction system and condition are:In the overall reaction system of 25 μ L, 1.0 μ L of genomic DNA, upstream and downstream primer is each 0.5 μ L, Taq archaeal dna polymerase, 2.5 μ L, dNTP Mix is 10 μ L, adds RNase Free water to 25 μ L;The RT-PCR reaction Reaction condition is:95 DEG C of initial denaturation 4min, into circulation;95 DEG C of denaturation 45s, 60 DEG C of annealing 45s, 72 DEG C of extension 1kb/min are followed Ring 35 times, last 72 DEG C of extensions 10min.
C. rIL2-IFN γ gene is obtained using flexible linker connection pig IL-2 and porcine IFN γ target gene
The PCR reaction system and reaction condition of connection be:In the overall reaction system of 25 μ L, connect flexible linker's 1 μ L of IL-2 gene template DNA connects 1 μ L, IL-2 upstream primer of IFN-γ template DNA, the 0.5 μ L of flexible linker, 0.5 μ L, Taq archaeal dna polymerase of IFN-γ downstream primer, 2.5 μ L, dNTP Mix is 10 μ L, adds RNase Free water to 25 μ L;Even Connecing PCR reaction condition is:95 DEG C of initial denaturation 4min, into circulation:94 DEG C of denaturation 45s;60 DEG C of annealing 45s, 72 DEG C of extension 1kb/ Min, totally 35 recycle;Last 72 DEG C of extensions 10min.
D. rIL2-IFN γ-IFN is obtained using flexible linker connection rIL2-IFN γ gene and pig IFN-α target gene α gene
The PCR reaction system and reaction condition of connection be:In the overall reaction system of 25 μ L, rIL2-IFN γ gene template 1 μ L of DNA connects 1 μ L, IL-2 upstream primer of IFN-α template DNA, the 0.5 μ L of flexible linker, IFN-α downstream primer 0.5 2.5 μ L, dNTP Mix of μ L, Taq archaeal dna polymerase is 10 μ L, adds RNase Free water to 25 μ L;Connecting PCR reaction condition is: 95 DEG C of initial denaturation 4min, into circulation:94 DEG C of denaturation 45s;60 DEG C of annealing 45s, 72 DEG C of extension 1kb/min, totally 35 recycle;Most 72 DEG C of extension 10min afterwards.
The present invention also provides the application of the Recombinant Swine long-acting interferon, long half time had up to 76 hours or more Broad-spectrum disease resistance toxic action and the immune response that pig itself can be improved.
Compared with prior art, the present invention has the advantages that:
1. pig IL-2, porcine IFN γ and pig IFN-α gene are realized amalgamation and expression by flexibility linker, interference is improved Plain half-life period improves 19 times or more compared with plain interferon;It is significant to drop compared with common polyethylene glycol fused interferon Low cost.
2. by being optimized to pig IL-2, porcine IFN γ and pig IFN-α gene, improve pig IL-2, porcine IFN γ and The expression quantity of pig IFN-α fusion protein.
3. using recombination bacillus coli pET-32a/rIL2-IFN γ-IFN α as expression bacterial strain, by introducing molecular chaperones PGro7 plasmid, in protein expression, generation inclusion body is less, forms great amount of soluble albumen, avoids inclusion body denaturation and answers The process of property, substantially reduces the time of expressing fusion protein;
4. the fusion protein disclosed by the invention being made of pig IL-2, porcine IFN γ and pig IFN-α not only has IFN-α Broad-spectrum disease resistance toxic action, while significantly improving the immune response of pig itself.
Detailed description of the invention
Fig. 1 is pig interleukin 2 and 6 gene, porcine interferon alpha gene and the Porcine interferon-gamma gene RT-PCR in embodiment 1 The result of amplification;Swimming lane M:DNA Marker DL2000;Swimming lane 1:2 gene RT-PCR amplified production of porcine interleukin;Swimming lane 2:Pig Interferon-gamma gene RT-PCR amplified production;Swimming lane 3:Porcine interferon alpha gene RT-PCR amplified production;
Fig. 2 be embodiment 1 in pig IL-2, IFN-γ connected with the target gene of IFN-α after PCR amplification knot Fruit;Swimming lane M:DNA Marker DL2000;Swimming lane 1:2 gene of porcine interleukin, Porcine interferon-gamma gene and porcine interferon alpha gene Ligation amplification product;
Fig. 3 is the PCR amplification and double digestion qualification result of the positive colony plasmid in embodiment 1;Swimming lane M:DNA Marker DL10000;Swimming lane 1:Plasmid PCR result;Swimming lane 2:Recombinant plasmid double digestion result;
Fig. 4 is the SDS-PAGE electrophoretic examinations result of the recombinant protein in embodiment 1;Swimming lane M:Albumen Marker;Swimming lane 1:Zero load control;Swimming lane 2:It is precipitated after bacterial cell disruption after recombinant bacterium induction;Swimming lane 3:After bacterial cell disruption after recombinant bacterium induction Supernatant;
Fig. 5 is the Western Blot qualification result for the fusion protein that embodiment 1 obtains;Swimming lane M:Albumen Marker;Swimming Road 1:It is precipitated after recombinant bacterium induction is broken;Swimming lane 2:For the broken rear supernatant of recombinant bacterium induction;
Fig. 6 is that the Recombinant Swine long-acting interferon α as made from the fusion protein in embodiment 1 causes cell to VSV in embodiment 5 The inhibiting effect of lesion;1 is VSV virus control wells;2 be HEp-2 cell control well;A3-12 is gradient dilution (from right to left) Human interferon standard items handle hole;B3-12 is that the Recombinant Swine long-acting interferon α of gradient dilution (from right to left) handles hole;
Fig. 7 is the Recombinant Swine long-acting interferon α intramuscular injection blood as made from the fusion protein in embodiment 1 in embodiment 8 Concentration-time changing curve.
Specific embodiment
Embodiment 1
A kind of fusion protein being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha, preparation method is such as Under:
1. pig interleukin 2 and 6 (IL-2), Porcine interferon-gamma (IFN-γ) and porcine interferon alpha (IFN-α) target gene It obtains and expands
Design of primers:
Synthetic primer is designed according to objective gene sequence reported in Genebank and is shown in Table 1, in pig interleukin 2 and 6 NcoI restriction enzyme site and Linker sequence are introduced in upstream primer and downstream primer respectively, Porcine interferon-gamma upstream primer and Linker sequence is introduced in downstream primer respectively, introduces Linker respectively in the upstream primer and downstream primer of porcine interferon alpha Sequence and XhoI restriction enzyme site.
1 PCR amplification primer of table
RT-PCR obtains target gene:
RNA is extracted from pig liver tissue, and the purpose base of pig IL-2, porcine IFN γ and pig IFN-α is obtained by reverse transcription Cause, the gene order of three respectively such as 400 < of SEQUENCE LISTING, 4 >, 400 < of SEQUENCE LISTING, 5 > and Shown in 400 < of SEQUENCE LISTING, 6 >;
RT-PCR reaction system (25 μ L) is shown in Table 2
2 RT-PCR reaction system of table
RNase Free water 10μL
dNTP Mix 10μL
Reverse transcriptase 2.5μL
Upstream and downstream primer Each 0.5 μ L
Geneome RNA 1.5μL
Response parameter is:50 DEG C of reverse transcriptions 30min, 95 DEG C of initial denaturation 4min, into circulation:95 DEG C of denaturation 45s;58 DEG C are moved back Fiery 45s, 72 DEG C of extension 1kb/min, totally 35 recycle;Last 72 DEG C of extensions 10min.
There is specific band in 490bp, 560bp and 710bp or so through agarose gel electrophoresis in RT-PCR amplified production, As a result as shown in Figure 1, illustrating that pig IL-2, porcine IFN γ and the pig for being separately connected flexible linker sequence have been prepared respectively The target gene of IFN-α.
2. the connection of target gene
Target gene is diluted to 10ug/mL, connects each section of target gene using over-lap PCR, 25 μ L reaction systems are such as Shown in table 3, table 4:
3 rIL2-IFN γ PCR reaction system of table
4 rIL2-IFN γ of table-IFN α PCR reaction system
Response parameter is:95 DEG C of initial denaturation 4min, into circulation:94 DEG C of denaturation 45s;58 DEG C of annealing 45s, 72 DEG C of extensions 1kb/min, totally 35 recycle;Last 72 DEG C of extensions 10min.
There is specific band in 1700bp or so through agarose gel electrophoresis in pcr amplification product, result as shown in Fig. 2, Occur rIL2-IFN γ and IFN-α amplified product band in Fig. 2, this is because connecting in rIL2-IFN γ with IFN-α gene During, there is non-specific responding.The nucleotide sequence of obtained target gene such as 400 < of SEQUENCE LISTING, 2 > It is shown.
3. expression vector establishment
For target gene after selection connection after sequencing is errorless, PCR glue recovery product and pET-32a plasmid use NcoI Double digestion and recycling are carried out with XhoI restriction enzyme, does double digestion by 20 μ L systems in table 5:
5 double digestion system of table
General buffer 2μL
Restriction enzyme (a pair) 1μL+1μL
Carrier or recycling segment 2ul
RNase Free water 14μL
The digestion recovery product of target gene and pET-32a plasmid after connection is attached by the system in table 6,4 DEG C overnight connection:
6 enzyme disjunctor system of table
Connection product is converted into e. coli bl21 (DE3) competent cell, competent cell is coated on benzyl containing ammonia The LB culture medium flat plate of penicillin is incubated overnight;Single colonie on picking LB plate carries out target gene PCR identification, positive colony Bacteria plasmid identifies that being accredited as positive indicates that engineering bacteria constructs successfully, and PCR amplification and double digestion are produced through NcoI and XhoI double digestion Object detects single band at the place 1700bp or so through agarose gel electrophoresis, and result is as shown in figure 3, illustrate successfully to obtain PET-32a/rIL2-IFN γ-IFN α engineering bacteria.
4. the expression of recombinant protein
Picking engineering bacteria 37 DEG C of shaking table recovery 1h in the LB culture medium containing 100 μ g/ml ampicillins, in LB culture medium Amplification culture 4h (OD=1.0) in (the 100 μ g/ml containing ampicillin), is added the IPTG of final concentration of 100 μ g/ml, 32 DEG C lure Lead expression 5h;Thallus is collected, through SDS-PAGE electrophoresis detection, result is as shown in figure 4, it can be seen from the figure that recombinant bacterium lures Supernatant is deposited in the visible predominant expression band in the place 80.6KD or so after bacterial cell disruption after leading 5h, illustrates in precipitating and supernatant Equal successful expression fusion protein.
Mass volume ratio 1 is added:Precipitating is resuspended in 1 PBS;- 20 DEG C precipitate 3 times in room temperature multigelation;4 DEG C of ultrasound cracking Bacterial precipitation, work 10s, is spaced 3S, ultrasonic 6min, and whole process repeats 3~4 times;4 DEG C, 12000r/min is centrifuged 15min, Supernatant, inclusion body (inclusion body is through dissolution, refolding strategy) are taken respectively, obtain crude fusion protein.
5. fusion protein purification
5.1 His affinity chromatographys
After membrane filtration of the crude fusion protein with 0.22 μm of aperture, loading is by being connected to AKTA explorer 100 On protein purification system, the His affinity column balanced with Binding Buffer I (PBS) is washed away not with PBS buffer solution In conjunction with albumen, until A280nm stablizes, then with Elution buffer I (50mM trishydroxymethylaminomethane, 20~500mM Imidazoles, PH8.0) elution, collect rIL2-IFN γ-IFN α protein peak.
5.2 DEAE anion-exchange chromatographies
By the albumen collected after His affinitive layer purification displacement to (the 50mM trihydroxy methyl of Binding Buffer II Aminomethane, PH6.5) in after, loading by the DEAE anion exchange chromatography that has been balanced with Binding Buffer II, then After being stablized with the column of Binding Buffer II to A280nm value, with (the 50mM trihydroxy methyl amino first of Elution Buffer II Alkane, 1M NaCl, PH6.5) linear gradient elution, collect rIL2-IFN γ-IFN α protein peak.
5.3 sieve chromatography
Loading is by with III (50mM of Binding Buffer after the sample concentration that ion-exchange chromatography is collected into Na2HPO4,0.15M NaCl, PH7.4) 200 molecular sieve chromatography of Superdex has been balanced, it is washed with Binding Buffer III It is de-, collect rIL2-IFN γ-IFN α protein peak.
5.4 sample identification
Measure rIL2-IFN γ-IFN α potency and specific activity, specific activity >=107U/mg, albumen are qualified;It is aseptic subpackaged, -80 DEG C save.The fusion protein being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha, amino acid sequence can be obtained Column are as shown in 400 < of SEQUENCE LISTING, 1 >.
Embodiment 2
A kind of fusion protein being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha, other same embodiments 1, only e. coli bl21 therein (DE3) competent cell is replaced in order to which the BL21 (DE3) with pGro7 plasmid experiences State cell.The SDS-PAGE electrophoresis result of its fusion protein is compareed with embodiment 1,80.6KD or so place's predominant expression in supernatant Band is thicker, illustrates after introducing molecular chaperones pGro7, expression of the destination protein in supernatant is more preferable, obtained fusion protein It measures higher.The albumen of Bacillus coli expression is mostly present in inclusion body;By introducing molecular chaperones in expression bacterial strain, assist It is correctly folded with expression albumen, reaches solubility expression of protein.
BL21 (DE3) competent cell with pGro7 plasmid is purchased from Shanghai Jinan Technology Co., Ltd./glad hundred promise Biology, article No. V205.
Embodiment 3
A kind of fusion protein being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha, preparation method is such as Under:
1. pig interleukin 2 and 6 (IL-2), Porcine interferon-gamma (IFN-γ) and porcine interferon alpha (IFN-α) target gene It obtains and expands
Pig IL-2, porcine IFN γ and pig IFN-α in embodiment 1 is optimized, artificially synthesized pig IL-2, porcine IFN γ With pig IFN-α target gene, after optimization, the nucleotide sequence of three respectively as 400 < of SEQUENCE LISTING, 7 >, Shown in 400 < of SEQUENCE LISTING 400 <, 8 > and SEQUENCE LISTING, 9 >.
1.1 codon optimization
Genetic codon has 64 kinds, but most biological tendencies are in utilizing a part in these codons.Those By the most frequent referred to as best codon (optimal codons) utilized, what those were not frequently utilized that is known as rare or utilizes The low codon of rate (rare or low-usage codons).In fact, common every kind of biology for doing protein expression or production (including Escherichia coli, yeast, mammalian cell, plant cell and insect cell) all shows the benefit of codon to a certain degree Difference or preference.The expression efficiency of the gene containing best codon is apparently higher than in Escherichia coli, yeast and drosophila and is contained The expression efficiency of the gene of the codon of poor efficiency.Therefore, in heterologous expression system, the preferences of codon are largely On affect the expression of recombinant protein.Using preference codon (preferred codons) and avoid utilizing rare codon Gene chemical synthesis is carried out, the redesign of this gene is codon optimization.Therefore, to the IL-2 of pig, pig IFN- in the present embodiment γ and pig IFN-α gene codon optimize.
Interpretation of result after 1.2 codon optimizations
It is optimal efficient in the expression system to be considered the gene when usual codon adaptation indexI (CAI)=1.0 Expression status, CAI value is lower to show that expression is lower in host.In gene G/C content most ideal distribution range be 30~ 70%, it is more than that the range will affect translation and transcriptional efficiency in any region.Pig IL-2, pig are found using software detection The codon of IFN-γ and pig IFN-α original gene codon adaptation indexI (CAI) in Escherichia coli is respectively 0.23, 0.24,0.22, GC percentage is 38.7%, 39.2%, 59.1%;And by pig IL-2, porcine IFN γ and pig IFN-α gene It is respectively 0.97,1.0,1.0, GC percentage that recombination codon adaptation indexI (CAI) in Escherichia coli is obtained after optimization 47.6%, 45.4%, 55.6%.The utilization rate of low codon is significantly reduced by gene optimization, avoids rare codon Influence to protein expression improves the G/C content of gene, improves transcription and translation efficiency, and then improves the table of recombinant protein Up to amount.
1.3 design of primers:
7 PCR amplification primer of table
The genomic DNA of pig IL-2, porcine IFN γ and pig IFN-α after optimization are diluted to 0.05mg/mL respectively.It utilizes PCR amplification obtains target gene, and 25 μ L reaction systems are as shown in table 8:
8 PCR reaction system of table
RNase Free water 10.5μL
dNTP Mix 10.0μL
Taq archaeal dna polymerase 2.5μL
Upstream and downstream primer Each 0.5 μ L
Genomic DNA 1.0μL
Response parameter is:95 DEG C of initial denaturation 4min, into circulation:95 DEG C of denaturation 45s;60 DEG C of annealing 45s, 72 DEG C of extensions 1kb/min, totally 35 recycle;Last 72 DEG C of extensions 10min.
The pcr amplification product of pig IL-2, porcine IFN γ and pig IFN-α through agarose gel electrophoresis respectively 490bp, There is specific band in 560bp and 710bp or so, illustrate that the pig for being separately connected flexible linker after optimization has been prepared The target gene of IL-2, porcine IFN γ and pig IFN-α.
2. the connection of target gene
Target gene is diluted to 10ug/mL, connects each section of target gene using over-lap PCR, 25 μ L reaction systems are such as Shown in table 9, table 10:
9 rIL2-IFN γ PCR reaction system of table
10 rIL2-IFN γ of table-IFN-α PCR reaction system
Response parameter is:95 DEG C of initial denaturation 4min, into circulation:94 DEG C of denaturation 45s;60 DEG C of annealing 45s, 72 DEG C of extensions 1kb/min, totally 35 recycle;Last 72 DEG C of extensions 10min.
There is specific band in 1700bp or so through agarose gel electrophoresis in pcr amplification product, illustrates successfully to be connected RIL2-IFN γ-IFN-α gene after connecing.The nucleotide sequence of obtained target gene such as SEQUENCE LISTING 400 Shown in 3 > of <.
3. expression vector establishment
The glue recovery product for the PCR for selecting the target gene after connecting errorless after being sequenced is used with pET-32a plasmid NcoI, XhoI restriction enzyme carry out double digestion and recycling, do double digestion by 20 μ L systems in table 11:
11 double digestion system of table
General buffer 2μL
Restriction enzyme (a pair) 1μL+1μL
Carrier or recycling segment 2ul
RNase Free water 14μL
The digestion recovery product of target gene and pET-32a plasmid after connection is attached by the system in table 12,4 DEG C overnight connection:
Table 12
Connection product is converted into e. coli bl21 (DE3) competent cell, competence is coated on the mould of benzyl containing ammonia It is incubated overnight in the LB plate of element;The bacterium colony grown on LB plate is taken to identify target gene, positive colony bacteria plasmid warp through PCR The identification of NcoI, XhoI double digestion, being accredited as positive indicates expression vector establishment success, and PCR amplification and double enzyme digestion product are through fine jade There is single band at the place 1700bp or so in sepharose electrophoresis, illustrates containing rIL2-IFN γ-IFN α fusion gene engineering bacterium PET-32a/rIL2-IFN γ-IFN α constructs successfully.
4. the expression of recombinant protein
Picking engineering bacteria 37 DEG C of shaking table recovery 1h in the LB culture medium containing 100 μ g/ml ampicillins, in LB culture medium Amplification culture 4h (OD=1.0) in (the 100 μ g/ml containing ampicillin), is added the IPTG of final concentration of 100 μ g/ml, 32 DEG C lure Lead expression 5h;Thallus is collected, through SDS-PAGE electrophoresis detection, supernatant is deposited in after the bacterial cell disruption after recombinant bacterium induction 5h The visible predominant expression band in the place 80.6KD or so illustrates to have obtained recombinant protein in supernatant precipitating.
Mass volume ratio 1 is added:Precipitating is resuspended in 1 PBS;- 20 DEG C precipitate 3 times in room temperature multigelation;4 DEG C of ultrasound cracking Bacterial precipitation, work 10s, is spaced 3S, ultrasonic 6min, and whole process repeats 3~4 times;4 DEG C, 12000r/min is centrifuged 15min, Supernatant, inclusion body (inclusion body is through dissolution, refolding strategy) are taken respectively, obtain crude fusion protein.
5. fusion protein purification
5.1 His affinity chromatographys
After membrane filtration of the crude fusion protein with 0.22 μm of aperture, loading is by being connected to AKTA explorer 100 On protein purification system, the His affinity column balanced with Binding Buffer I (PBS) is washed away not with PBS buffer solution In conjunction with albumen, until A280nm stablizes, then with Elution buffer I (50mM trishydroxymethylaminomethane, 20~500mM Imidazoles, PH8.0) elution, collect rIL2-IFN γ-IFN α protein peak.
5.2 DEAE anion-exchange chromatographies
By the albumen collected after His affinitive layer purification displacement to (the 50mM trihydroxy methyl of Binding Buffer II Aminomethane, PH6.5) in after, loading by the DEAE anion exchange chromatography that has been balanced with Binding Buffer II, then After being stablized with the column of Binding Buffer II to A280nm value, with (the 50mM trihydroxy methyl amino first of Elution Buffer II Alkane, 1M NaCl, PH6.5) linear gradient elution, collect rIL2-IFN γ-IFN α protein peak.
5.3 sieve chromatography
Loading is by with Binding Buffer III after the sample concentration that ion-exchange chromatography is collected into (50mMNa2HPO4,0.15M NaCl, PH7.4) 200 molecular sieve chromatography of Superdex has been balanced, with Binding Buffer III elution, collects rIL2-IFN γ-IFN α protein peak.
5.4 sample identification
Measure rIL2-IFN γ-IFN α potency and specific activity, specific activity >=107U/mg, albumen are qualification;It is aseptic subpackaged ,- 80 DEG C of preservations.The fusion protein being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha, amino acid can be obtained Sequence is as shown in 400 < of SEQUENCE LISTING, 1 >.
Embodiment 4
A kind of fusion protein being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha, other same embodiments 3, only e. coli bl21 therein (DE3) competent cell is replaced in order to which the BL21 (DE3) with pGro7 plasmid experiences State cell.The SDS-PAGE electrophoresis result of its fusion protein is compareed with embodiment 3,80.6KD or so place's predominant expression in supernatant Band is thicker, illustrates after introducing molecular chaperones pGro7, expression of the destination protein in supernatant is more preferable, obtained fusion protein It measures higher.The albumen of Bacillus coli expression is mostly present in inclusion body;By introducing molecular chaperones in expression bacterial strain, assist It is correctly folded with expression albumen, reaches solubility expression of protein.
BL21 (DE3) competent cell with pGro7 plasmid is purchased from Shanghai Jinan Technology Co., Ltd./glad hundred promise Biology, article No. V205.
Embodiment 5
A kind of Recombinant Swine long-acting interferon α, it is mixed with freeze drying protectant respectively by the fusion protein in embodiment 1,2,3,4 Later, freeze-dried to form.The freeze drying protectant is glycerol, mannitol and sucrose, is buffer with 10mmol/L PBS, Final concentration of glycerol 100mL/L, mannitol 0.12g/mL and the sucrose 0.025g/mL of three.
Embodiment 6
Examples 1 to 4 obtains the mirror for the fusion protein being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha It is fixed
The quantitative detection of 6.1 protein contents
With Lowry method, standard test is made with the standard protein of Chinese food pharmaceutical biological product calibrating institute, measures embodiment 1~4 obtained fusion protein concentration is all larger than 1.1mg/ml.
6.2 SDS-PAGE electrophoresis detections
Compared with empty bacterium, fusion protein has the newly-increased protein band of a dense dye in 80.6KD or so, as shown in Figure 4.
6.3 Western Blot results
Fusion protein in Examples 1 to 4 is detected, respectively with the anti-porcine alpha-IFN (1 of abcam company mouse:5000 dilutions) it is one It is anti-, using goat anti-mouse IgG-HRP as secondary antibody (1:10000 dilutions).Recombinant Swine long-acting interferon sample can be with anti-porcine interferon alpha Specific reaction occurs for monoclonal antibody, and specific band occurs in the place 80.6KD or so, as shown in Figure 5.
Embodiment 7
Four parts of Recombinant Swine long-acting interferon α in embodiment 5 freeze-dried bioactivity
Inhibit method according to few cells lesion, Hep-2 cell is made into 5 × 10 with culture medium5Cell/ml cell suspends Liquid, every hole inoculation 0.1ml move into 96 porocyte culture plates.37 DEG C, 5%CO2For 24 hours, the Recombinant Swine that various dose is added is long for culture Interferon-' alpha ' is imitated, inhales abandon afterwards for 24 hours, then inoculation 100TCID50VSV virus respectively.
Test result
The result shows that the Recombinant Swine long-acting interferon α obtained causes the lesion of HEp-2 cell to have apparent inhibit VSV Effect.The lesions such as there is cell rounding, falls off, is disintegrated after untreated cell inoculation virus.And the Recombinant Swine obtained is long After imitating interferon-' alpha ' treated cell inoculation virus, it is observed continuously under inverted microscope, cellular morphology is normal, not incumbent out What lesion, measures potency >=107U/ml, as shown in Figure 6.
Embodiment 8
Being lyophilized respectively by four parts of Recombinant Swine long-acting interferon α that the fusion protein of Examples 1 to 4 obtains in embodiment 5 Measurement of the agent (being denoted as A, B, C, D respectively) in pig intracorporal half-life period
Cytopathic-effect inhibition assay measures rIL2-IFN γ-IFN α blood concentration and time relationship
The pig (half male and half female) that six weight are roughly the same is taken, 2mg/ml Recombinant Swine long-acting interferon α is subcutaneously injected in neck Freeze-dried 2ml, respectively in 1h, 2h, 4h, 8h, 16h, 36h, 72h, 96h venous blood collection, 4 DEG C of blood sample solidifications, 3500rpm low temperature from Heart 10min separates serum, and every pig blood sample of each time point is to be measured in -20 DEG C of preservations.Serum sample is measured using cytopathic-effect inhibition assay RIL2-IFN γ-IFN α concentration in product is carried out curve fitting and calculating parameter with DAS pharmacokinetics software.Parameter calculated result It is shown in Table 13.
Dominant dynamic parameters in serum after 13 Recombinant Swine long-acting interferon α intramuscular injection of table
The result shows that Recombinant Swine long-acting interferon α has longer half-life period.Half-life period can reach 76h or so after measured, compared with Plain interferon improves 19 times or more.
Embodiment 9
The freeze-dried measurement that pig cell immune response is influenced of four parts of Recombinant Swine long-acting interferon α in embodiment 5
It takes six roughly the same pigs of weight to be divided into two groups, is denoted as experimental group and control group;The subcutaneous injection of experimental group neck The PBS of 2mL is subcutaneously injected in the 2mg/ml Recombinant Swine long-acting interferon freeze-dried 2ml of α, control group neck, takes pig periphery after injection 4 weeks Blood takes weekly a blood later, separates lymphocyte using lymphocyte separation medium, lymphocyte passes through serum-free RPMI It after 1640 culture mediums wash 2 times, is resuspended with complete medium, adjustment cell concentration is 2 × 106A/ml, 24 porocyte culture plates are every Hole addition 1ml lymphocyte, 37 DEG C, 5%CO272h is cultivated, supernatant when collecting lymphocyte culture.ELISA detects culture supernatant Middle IL-4 content, is carried out by kit specification, and testing result is as shown in table 14:
It is horizontal that table 14ELISA detects each group pig cell immune response
The result shows that cell factor IL-4 in pig peripheral blood can be significantly improved after injection Recombinant Swine long-acting interferon α Content enhances cellullar immunologic response level, significantly improves immunity level.
It is above-mentioned referring to embodiment to a kind of fusion egg being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha The detailed description that bletilla preparation method carries out, is illustrative without being restrictive, can enumerate according to limited range Several embodiments, therefore the change and modification in the case where not departing from present general inventive concept, should belong to protection scope of the present invention it It is interior.
SEQUENCE LISTING
<110>Wuhu Co., Ltd of Ying Tefeier biological products industrial research institute
<120>A kind of fusion protein being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha and its preparation
Method
<130> 1
<160> 9
<170> PatentIn version 3.3
<210> 1
<211> 566
<212> PRT
<213>Pig IL2-IFN γ-IFN α fusion protein
<400> 1
Met Tyr Lys Met Gln Leu Leu Cys Cys Ile Ala Leu Thr Leu Ala Leu
1 5 10 15
Met Ala Asn Gly Ala Pro Thr Ser Ser Ser Thr Lys Asn Thr Lys Lys
20 25 30
Gln Leu Glu Pro Leu Leu Leu Asp Leu Gln Leu Leu Leu Lys Glu Val
35 40 45
Lys Asn Tyr Glu Asn Ala Asp Leu Ser Arg Met Leu Thr Phe Lys Phe
50 55 60
Tyr Met Pro Lys Gln Ala Thr Glu Leu Lys His Leu Gln Cys Leu Val
65 70 75 80
Glu Glu Leu Lys Ala Leu Glu Gly Val Leu Asn Leu Gly Gln Ser Lys
85 90 95
Asn Ser Asp Ser Ala Asn Ile Lys Glu Ser Met Asn Asn Ile Asn Val
100 105 110
Thr Val Leu Glu Leu Lys Gly Ser Glu Thr Ser Phe Lys Cys Glu Tyr
115 120 125
Asp Asp Glu Thr Val Thr Ala Val Glu Phe Leu Asn Lys Trp Ile Thr
130 135 140
Phe Cys Gln Ser Ile Tyr Ser Thr Leu Thr Gly Gly Gly Gly Ser Gly
145 150 155 160
Gly Gly Gly Ser Met Ser Tyr Thr Thr Tyr Phe Leu Ala Phe Gln Leu
165 170 175
Cys Val Thr Leu Cys Phe Ser Gly Ser Tyr Cys Gln Ala Pro Phe Phe
180 185 190
Lys Glu Ile Thr Ile Leu Lys Asp Tyr Phe Asn Ala Ser Thr Ser Gly
195 200 205
Val Pro Asn Gly Gly Pro Leu Phe Leu Glu Ile Leu Glu Asn Trp Lys
210 215 220
Glu Glu Ser Asp Lys Lys Ile Ile Gln Ser Gln Ile Val Ser Phe Tyr
225 230 235 240
Phe Lys Phe Phe Glu Ile Phe Lys Asp Asn Gln Ala Ile Gln Arg Ser
245 250 255
Met Asp Val Ile Lys Gln Asp Met Phe Gln Arg Phe Leu Asn Gly Ser
260 265 270
Ser Gly Lys Leu Asn Asp Phe Glu Lys Leu Val Lys Ile Pro Val Asp
275 280 285
Asn Leu Gln Ile Gln Arg Lys Ala Ile Ser Glu Leu Ile Lys Val Met
290 295 300
Asn Asp Leu Ser Pro Arg Ser Asn Leu Arg Lys Arg Lys Arg Ser Gln
305 310 315 320
Thr Met Phe Gln Gly Gln Arg Ala Ser Lys Gly Gly Gly Gly Ser Gly
325 330 335
Gly Gly Gly Ser Met Cys Ser Tyr Leu Arg His Arg Pro Glu Gly Arg
340 345 350
Ser Ser Asn Ile Leu Glu Ser Arg Val Thr Glu Ser Pro Thr Ser Ala
355 360 365
Arg Thr Ala Ala Ser Ala Arg Ser Pro Met Ala Pro Thr Ser Ala Phe
370 375 380
Leu Thr Ala Leu Val Leu Leu Ser Cys Asn Ala Ile Cys Ser Leu Gly
385 390 395 400
Cys Asp Leu Pro Gln Thr His Ser Leu Ala His Thr Arg Ala Leu Arg
405 410 415
Leu Leu Ala Gln Met Arg Arg Ile Ser Pro Phe Ser Cys Leu Asp His
420 425 430
Arg Arg Asp Phe Gly Phe Pro Gln Glu Ala Leu Gly Gly Asn Gln Val
435 440 445
Gln Lys Ala Gln Ala Met Ala Leu Val His Glu Met Leu Gln Gln Thr
450 455 460
Phe Gln Leu Phe Ser Thr Glu Gly Ser Ala Ala Ala Trp Asp Glu Ser
465 470 475 480
Leu Leu His Gln Phe Cys Thr Gly Leu Asp Gln Gln Leu Arg Asp Leu
485 490 495
Glu Ala Cys Val Met Gln Glu Ala Gly Leu Glu Gly Thr Pro Leu Leu
500 505 510
Glu Glu Asp Ser Ile Leu Ala Val Arg Lys Tyr Phe His Arg Leu Thr
515 520 525
Leu Tyr Leu Gln Glu Lys Ser Tyr Ser Pro Cys Ala Trp Glu Ile Val
530 535 540
Arg Ala Glu Val Met Arg Ala Phe Ser Ser Ser Thr Asn Leu Gln Asp
545 550 555 560
Arg Leu Arg Arg Lys Glu
565
<210> 2
<211> 1698
<212> DNA
<213>Genome 1
<400> 2
atgtataaga tgcagctctt gtgttgcatt gcactaaccc ttgcactcat ggcaaacggt 60
gcacctactt caagctctac aaagaacaca aagaaacaac tggagccatt gctgctggat 120
ttacagttgc ttttgaagga agttaagaat tacgagaatg ctgatctctc caggatgctc 180
acatttaaat tttacatgcc caagcaggct acagaattga aacaccttca gtgtttagta 240
gaagaactca aagctctgga gggagtgcta aatttaggtc aaagcaaaaa ctctgactca 300
gcaaatatca aggaatcaat gaacaatatc aacgtaacag ttttggaact aaagggatct 360
gaaacaagtt tcaaatgtga atatgatgat gagacagtaa ctgctgttga atttctgaac 420
aaatggatta ccttttgtca aagcatctac tcaacactga ctggtggtgg tggttctggt 480
ggtggtggtt ctatgagtta tacaacttat ttcttagctt ttcagctttg cgtgactttg 540
tgtttttctg gctcttactg ccaggcgccc ttttttaaag aaataacgat cctaaaggac 600
tattttaatg caagtacctc aggtgtacct aatggtggac ctcttttctt agaaattttg 660
gagaattgga aagaggagag tgacaaaaaa ataattcaga gccaaattgt ctccttctac 720
ttcaaattct ttgaaatctt caaagataac caggccattc aaaggagcat ggatgtgatc 780
aagcaagaca tgtttcagag gttcctaaat ggtagctctg ggaaactgaa tgacttcgaa 840
aagctggtta aaattccggt agataatctg cagatccagc gcaaagccat cagtgaactc 900
atcaaagtga tgaatgatct gtcaccaaga tctaacctaa gaaagcggaa gagaagtcag 960
actatgttcc aaggccagag agcatcaaaa ggtggtggtg gttctggtgg tggtggttct 1020
atgtgttcct atttaagaca caggcctgag ggaaggtctt caaacatcct agagagcagg 1080
gtcacagagt cacccacctc agccaggaca gcagcatctg caaggtcccc aatggcccca 1140
acctcagcct tcctcacggc cctggtgctg ctcagctgca atgccatctg ctctctgggc 1200
tgcgacctgc ctcagaccca cagcctggct cacaccaggg ccctgaggct cctggcacaa 1260
atgaggagaa tctccccctt ctcctgcctg gaccacagaa gggactttgg attcccccaa 1320
gaggccttgg ggggcaacca ggtccagaag gctcaagcca tggctctggt gcatgagatg 1380
ctccagcaga ccttccagct cttcagcaca gagggctcgg ctgctgcctg ggatgagagc 1440
ctcctgcacc agttctgcac tggactggat cagcagctca gggacctgga agcctgtgtc 1500
atgcaggagg ccgggctgga agggaccccc ctgctggagg aggactccat cctggctgtg 1560
aggaaatact tccacagact caccctctat ctgcaagaga agagctacag cccctgtgcc 1620
tgggagatcg tcagggcaga agtcatgaga gccttctctt cctccacaaa cctgcaagac 1680
agactcagga ggaaggag 1698
<210> 3
<211> 1698
<212> DNA
<213>Genome 2
<400> 3
atgtacaaaa tgcagctgct gtgctgcatc gctctgaccc tggctctgat ggctaacggt 60
gctccgacct cttcttctac caaaaacacc aaaaaacagc tggaaccgct gctgctggac 120
ctgcagctgc tgctgaaaga agttaaaaac tacgaaaacg ctgacctgtc tcgtatgctg 180
accttcaaat tctacatgcc gaaacaggct accgaactga aacacctgca gtgcctggtt 240
gaagaactga aagctctgga aggtgttctg aacctgggtc agtctaaaaa ctctgactct 300
gctaacatca aagaatctat gaacaacatc aacgttaccg ttctggaact gaaaggctcg 360
gaaaccagct tcaaatgcga atacgacgac gaaaccgtta ccgctgttga attcctgaac 420
aaatggatca ccttctgcca gtctatctac tctaccctga ccggtggtgg tggttctggt 480
ggtggtggtt ctatgtctta caccacctac ttcctggctt tccagctgtg cgttaccctg 540
tgcttctctg gttcttactg ccaggctccg ttcttcaaag aaatcaccat cctgaaagac 600
tacttcaacg cttctacctc tggtgttccg aacggtggtc cgctgttcct ggaaatcctg 660
gaaaactgga aagaagaatc tgacaaaaaa atcatccagt ctcagatcgt ttctttctac 720
ttcaaattct tcgaaatctt caaagacaac caggctatcc agcgttctat ggacgttatc 780
aaacaggaca tgttccagcg tttcctgaac ggttcttctg gtaaactgaa cgacttcgaa 840
aaactggtta aaatcccggt tgacaacctg cagatccagc gtaaagctat ctctgaactg 900
atcaaagtta tgaacgacct gtctccgcgt tctaacctgc gtaaacgtaa acgttctcag 960
accatgttcc agggtcagcg tgcttctaaa ggtggtggtg gttctggtgg tggtggttct 1020
atgtgctctt acctgcgtca ccgtccggaa ggtcgttctt ctaacatcct ggaatctcgt 1080
gttaccgaat ctccgacctc tgctcgtacc gctgcttctg ctcgttctcc gatggctccg 1140
acctctgctt tcctgaccgc tctggttctg ctgtcttgca acgctatctg ctctctgggt 1200
tgcgacctgc cgcagaccca ctctctggct cacacccgtg ctctgcgtct gctggctcag 1260
atgcgtcgta tctctccgtt ctcttgcctg gaccaccgtc gtgacttcgg tttcccgcag 1320
gaagctctgg gtggtaacca ggttcagaaa gctcaggcta tggctctggt tcacgaaatg 1380
ctgcagcaga ccttccagct gttctctacc gaaggttctg ctgctgcttg ggacgaatct 1440
ctgctgcacc agttctgcac cggtctggac cagcagctgc gtgacctgga agcttgcgtt 1500
atgcaggaag ctggtctgga aggtaccccg ctgctggaag aagactctat cctggctgtt 1560
cgtaaatact tccaccgtct gaccctgtac ctgcaggaaa aatcttactc tccgtgcgct 1620
tgggaaatcg ttcgtgctga agttatgcgt gctttctctt cttctaccaa cctgcaggac 1680
cgtctgcgtc gtaaagaa 1698
<210> 4
<211> 462
<212> DNA
<213>Pig IL-2
<400> 4
atgtataaga tgcagctctt gtgttgcatt gcactaaccc ttgcactcat ggcaaacggt 60
gcacctactt caagctctac aaagaacaca aagaaacaac tggagccatt gctgctggat 120
ttacagttgc ttttgaagga agttaagaat tacgagaatg ctgatctctc caggatgctc 180
acatttaaat tttacatgcc caagcaggct acagaattga aacaccttca gtgtttagta 240
gaagaactca aagctctgga gggagtgcta aatttaggtc aaagcaaaaa ctctgactca 300
gcaaatatca aggaatcaat gaacaatatc aacgtaacag ttttggaact aaagggatct 360
gaaacaagtt tcaaatgtga atatgatgat gagacagtaa ctgctgttga atttctgaac 420
aaatggatta ccttttgtca aagcatctac tcaacactga ct 462
<210> 5
<211> 498
<212> DNA
<213>Porcine IFN γ
<400> 5
atgagttata caacttattt cttagctttt cagctttgcg tgactttgtg tttttctggc 60
tcttactgcc aggcgccctt ttttaaagaa ataacgatcc taaaggacta ttttaatgca 120
agtacctcag gtgtacctaa tggtggacct cttttcttag aaattttgga gaattggaaa 180
gaggagagtg acaaaaaaat aattcagagc caaattgtct ccttctactt caaattcttt 240
gaaatcttca aagataacca ggccattcaa aggagcatgg atgtgatcaa gcaagacatg 300
tttcagaggt tcctaaatgg tagctctggg aaactgaatg acttcgaaaa gctggttaaa 360
attccggtag ataatctgca gatccagcgc aaagccatca gtgaactcat caaagtgatg 420
aatgatctgt caccaagatc taacctaaga aagcggaaga gaagtcagac tatgttccaa 480
ggccagagag catcaaaa 498
<210> 6
<211> 678
<212> DNA
<213>Pig IFN-α
<400> 6
atgtgttcct atttaagaca caggcctgag ggaaggtctt caaacatcct agagagcagg 60
gtcacagagt cacccacctc agccaggaca gcagcatctg caaggtcccc aatggcccca 120
acctcagcct tcctcacggc cctggtgctg ctcagctgca atgccatctg ctctctgggc 180
tgcgacctgc ctcagaccca cagcctggct cacaccaggg ccctgaggct cctggcacaa 240
atgaggagaa tctccccctt ctcctgcctg gaccacagaa gggactttgg attcccccaa 300
gaggccttgg ggggcaacca ggtccagaag gctcaagcca tggctctggt gcatgagatg 360
ctccagcaga ccttccagct cttcagcaca gagggctcgg ctgctgcctg ggatgagagc 420
ctcctgcacc agttctgcac tggactggat cagcagctca gggacctgga agcctgtgtc 480
atgcaggagg ccgggctgga agggaccccc ctgctggagg aggactccat cctggctgtg 540
aggaaatact tccacagact caccctctat ctgcaagaga agagctacag cccctgtgcc 600
tgggagatcg tcagggcaga agtcatgaga gccttctctt cctccacaaa cctgcaagac 660
agactcagga ggaaggag 678
<210> 7
<211> 462
<212> DNA
<213>Pig IL-2
<400> 7
atgtacaaaa tgcagctgct gtgctgcatc gctctgaccc tggctctgat ggctaacggt 60
gctccgacct cttcttctac caaaaacacc aaaaaacagc tggaaccgct gctgctggac 120
ctgcagctgc tgctgaaaga agttaaaaac tacgaaaacg ctgacctgtc tcgtatgctg 180
accttcaaat tctacatgcc gaaacaggct accgaactga aacacctgca gtgcctggtt 240
gaagaactga aagctctgga aggtgttctg aacctgggtc agtctaaaaa ctctgactct 300
gctaacatca aagaatctat gaacaacatc aacgttaccg ttctggaact gaaaggctcg 360
gaaaccagct tcaaatgcga atacgacgac gaaaccgtta ccgctgttga attcctgaac 420
aaatggatca ccttctgcca gtctatctac tctaccctga cc 462
<210> 8
<211> 498
<212> DNA
<213>Porcine IFN γ
<400> 8
atgtcttaca ccacctactt cctggctttc cagctgtgcg ttaccctgtg cttctctggt 60
tcttactgcc aggctccgtt cttcaaagaa atcaccatcc tgaaagacta cttcaacgct 120
tctacctctg gtgttccgaa cggtggtccg ctgttcctgg aaatcctgga aaactggaaa 180
gaagaatctg acaaaaaaat catccagtct cagatcgttt ctttctactt caaattcttc 240
gaaatcttca aagacaacca ggctatccag cgttctatgg acgttatcaa acaggacatg 300
ttccagcgtt tcctgaacgg ttcttctggt aaactgaacg acttcgaaaa actggttaaa 360
atcccggttg acaacctgca gatccagcgt aaagctatct ctgaactgat caaagttatg 420
aacgacctgt ctccgcgttc taacctgcgt aaacgtaaac gttctcagac catgttccag 480
ggtcagcgtg cttctaaa 498
<210> 9
<211> 678
<212> DNA
<213>Pig IFN-α
<400> 9
atgtgctctt acctgcgtca ccgtccggaa ggtcgttctt ctaacatcct ggaatctcgt 60
gttaccgaat ctccgacctc tgctcgtacc gctgcttctg ctcgttctcc gatggctccg 120
acctctgctt tcctgaccgc tctggttctg ctgtcttgca acgctatctg ctctctgggt 180
tgcgacctgc cgcagaccca ctctctggct cacacccgtg ctctgcgtct gctggctcag 240
atgcgtcgta tctctccgtt ctcttgcctg gaccaccgtc gtgacttcgg tttcccgcag 300
gaagctctgg gtggtaacca ggttcagaaa gctcaggcta tggctctggt tcacgaaatg 360
ctgcagcaga ccttccagct gttctctacc gaaggttctg ctgctgcttg ggacgaatct 420
ctgctgcacc agttctgcac cggtctggac cagcagctgc gtgacctgga agcttgcgtt 480
atgcaggaag ctggtctgga aggtaccccg ctgctggaag aagactctat cctggctgtt 540
cgtaaatact tccaccgtct gaccctgtac ctgcaggaaa aatcttactc tccgtgcgct 600
tgggaaatcg ttcgtgctga agttatgcgt gctttctctt cttctaccaa cctgcaggac 660
cgtctgcgtc gtaaagaa 678

Claims (10)

1. a kind of fusion protein being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha, it is characterised in that:It is described The amino acid sequence table of fusion protein is as shown in 400 < of SEQUENCE LISTING, 1 >.
2. a kind of gene for encoding fusion protein as described in claim 1, which is characterized in that the nucleotide sequence of the gene Table is denoted as genome 1 as shown in 400 < of SEQUENCE LISTING, 2 >;Or as shown in 400 < of SEQUENCE LISTING, 3 >, It is denoted as genome 2.
3. containing the expression vector of gene as claimed in claim 2.
4. containing the genetic engineering bacterium of gene as claimed in claim 2.
5. a kind of Recombinant Swine long-acting interferon, which is characterized in that the Recombinant Swine long-acting interferon is melted by described in claim 1 It is freeze-dried to form after hop protein and freeze drying protectant mixture.
6. the preparation method of fusion protein according to claim 1, which is characterized in that the preparation method includes following step Suddenly:Expression vector as claimed in claim 3 is imported into e. coli host cell, genetic engineering bacterium, genetic engineering are obtained Bacterium obtains the crude product of the fusion protein after IPTG inducing expression, and fusion protein can be obtained after purified.
7. preparation method according to claim 6, which is characterized in that the genetic engineering bacterium is pET-32a/rIL2-IFN γ-IFN α, preparation method are:
(1) design primer, is obtained or the pig interleukin 2 and 6 of the flexible linker sequence of artificial synthesized band, pig by reverse transcription The target gene of interferon gamma, porcine interferon alpha;Pig interleukin 2 and 6, Porcine interferon-gamma, pig are interfered by flexible linker The target gene of plain α connects, the nucleotides sequence list of the target gene after connection such as 400 < of SEQUENCE LISTING, 2 > It is shown or as shown in 400 < of SEQUENCE LISTING, 3 >;
(2) target gene after connection is connected on pET-32a plasmid and obtains expression vector;
(3) expression vector is imported into e. coli host cell, genetic engineering bacterium pET-32a/rIL2-IFN can be obtained γ-IFNα。
8. preparation method according to claim 6 or 7, which is characterized in that the e. coli host cell is BL21 (DE3) competent cell or BL21 (DE3) competent cell with pGro7 plasmid.
9. preparation method according to claim 6 or 7, which is characterized in that the method for the purifying is:Fusion protein it is thick Product are successively through affinity chromatography, anion-exchange chromatography and molecular sieve chromatography purification.
10. the application of Recombinant Swine long-acting interferon according to claim 5, which is characterized in that the Recombinant Swine is long-acting dry The long half time of element is disturbed up to 76 hours or more, there is broad-spectrum disease resistance toxic action and the immune response of pig itself can be improved.
CN201810768483.8A 2017-08-09 2018-07-13 A kind of fusion protein and preparation method thereof being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha Withdrawn CN108840950A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2017106757288 2017-08-09
CN201710675728.8A CN107253994A (en) 2017-08-09 2017-08-09 A kind of fusion protein being made up of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha and preparation method thereof

Publications (1)

Publication Number Publication Date
CN108840950A true CN108840950A (en) 2018-11-20

Family

ID=60026714

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201710675728.8A Pending CN107253994A (en) 2017-08-09 2017-08-09 A kind of fusion protein being made up of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha and preparation method thereof
CN201810768483.8A Withdrawn CN108840950A (en) 2017-08-09 2018-07-13 A kind of fusion protein and preparation method thereof being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201710675728.8A Pending CN107253994A (en) 2017-08-09 2017-08-09 A kind of fusion protein being made up of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha and preparation method thereof

Country Status (1)

Country Link
CN (2) CN107253994A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110746501A (en) * 2019-11-11 2020-02-04 南京农业大学 Application of porcine interleukin 11 in resisting porcine epidemic diarrhea virus infection

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118165124B (en) * 2024-05-14 2024-07-19 北京伟杰信生物科技有限公司 Fusion protein of recombinant porcine interferon lambda 1, porcine interferon gamma and porcine Fc and application thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110746501A (en) * 2019-11-11 2020-02-04 南京农业大学 Application of porcine interleukin 11 in resisting porcine epidemic diarrhea virus infection

Also Published As

Publication number Publication date
CN107253994A (en) 2017-10-17

Similar Documents

Publication Publication Date Title
CN108840951A (en) A kind of fusion protein and preparation method thereof being made of pig albumin, Porcine interferon-gamma and porcine interferon alpha
CN108840947A (en) Bovine albumin-interferon-&#39; alpha &#39;-interleukin-22 fusion protein, preparation method and its encoding gene, a kind of ox long-acting interferon
CN108840952A (en) A kind of fusion protein and preparation method thereof being made of Chicken Albumin, chicken interferon gamma and chicken interferon α
CN108840946A (en) Dog albumin-interferon-&#39; alpha &#39;-interleukin-22 fusion protein, preparation method and its encoding gene, a kind of dog long-acting interferon
CN108794638A (en) A kind of recombinant bovine long-acting interferon α and the fusion protein and preparation method thereof for preparing this long-acting interferon
CN108840950A (en) A kind of fusion protein and preparation method thereof being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha
CN108840945A (en) Pig albumin-interferon-&#39; alpha &#39;-interleukin-22 fusion protein, preparation method and its encoding gene, a boar long-acting interferon
CN108822220A (en) Sheep albumin-interferon-tau-interleukin-22 fusion protein, preparation method and its encoding gene, a kind of sheep long-acting interferon
CN108864302A (en) A kind of fusion protein and preparation method thereof being made of pig albumin, Porcine interferon-gamma and pig interleukin 2 and 6
CN108794644A (en) A kind of fusion protein and preparation method thereof being made of cattle interleukins-2 2, Bov IFN γ and Bov IFN α
CN108840953A (en) A kind of fusion protein and preparation method thereof being made of sheep interleukin 2, sheep interferon gamma and sheep interferon-tau
CN108822221A (en) A kind of fusion protein and preparation method thereof being made of Chicken Albumin, chicken interferon gamma and recombinant chIL-2
CN108864295A (en) A kind of recombinant bovine long-acting interferon and the fusion protein for preparing this long-acting interferon and preparation method thereof
CN108794645A (en) A kind of fusion protein and preparation method thereof being made of bovine albumin, Bov IFN γ and Bov IFN α
CN108840935A (en) A kind of fusion protein being made of sheep albumin and sheep interferon gamma and preparation method thereof and a kind of recombination sheep long-acting interferon γ
CN108840934A (en) A kind of recombination sheep long-acting interferon τ and the fusion protein for preparing this long-acting interferon and preparation method thereof
CN108840941A (en) A kind of fusion protein and preparation method thereof for recombinating sheep long-acting interferon γ and preparing this long-acting interferon γ
CN108864300A (en) Chicken Albumin-interferon-&#39; alpha &#39;-interleukin-22 fusion protein, preparation method and its encoding gene, a breeder long-acting interferon
CN107245110A (en) A kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interferon-tau and preparation method thereof
CN108864301A (en) A kind of fusion protein and preparation method thereof being made of bovine albumin, Bov IFN γ and cattle interleukins-2 2
CN109053897A (en) A kind of fusion protein and preparation method thereof being made of recombinant chIL-2, chicken interferon gamma and chicken interferon α
CN108840942A (en) A kind of Recombinant Swine long-acting interferon and the fusion protein for preparing this long-acting interferon and preparation method thereof
CN108840944A (en) A kind of fusion protein and preparation method thereof being made of sheep albumin, sheep interferon gamma and sheep interleukin 2
CN108840936A (en) A kind of Recombinant Swine long-acting interferon α and the fusion protein for preparing this long-acting interferon and preparation method thereof
CN108864306A (en) A kind of fusion protein and preparation method thereof being made of canine leucocyte interleukin 2, dog interferon γ and dog interferon alpha

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20181120

WW01 Invention patent application withdrawn after publication